Lornoxicam

• Target :

  Endogenous Metabolite|||Interleukin|||COX|||Prostaglandin Receptor|||Apoptosis|||TNF|||NO Synthase

• Related Pathways :

  Immunology/Inflammation|||GPCR/G Protein|||Neuroscience|||Metabolism|||Apoptosis

• Purity :

  >99.99%

• Bioactivity :

  Lornoxicam (Chlortenoxicam) (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory, and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan.

• Smiles :

  CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O

• Molecular Formula :

  C13H10ClN3O4S2

• Molecular Weight :

  371.82

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  70374-39-9